Kuangli Bio-Tech Holdings Co., Ltd. (TPE:6431)
Taiwan · Delayed Price · Currency is TWD 16.30
-0.10 (-0.61%)
Jul 30, 2026, 1:30 PM CST
Kuangli Bio-Tech Holdings Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 188.04 | 208.93 | 41.59 | 63.22 | 141.89 | 162.17 |
Short-Term Investments | - | - | - | 9.19 | - | - |
Cash & Short-Term Investments | 188.04 | 208.93 | 41.59 | 72.41 | 141.89 | 162.17 |
Cash Growth | -43.36% | 402.40% | -42.57% | -48.97% | -12.51% | 41.71% |
Accounts Receivable | 77.49 | 85.26 | 101.82 | 73.01 | 96.86 | 135.93 |
Other Receivables | 4.65 | 0.41 | 2.01 | 0.28 | 1.84 | 85.76 |
Receivables | 82.13 | 85.66 | 118.53 | 135.86 | 163.32 | 231.68 |
Inventory | 62.06 | 53.36 | 64.24 | 52.13 | 63.65 | 98.87 |
Prepaid Expenses | - | - | 2.69 | 2.79 | 9.78 | 9.55 |
Other Current Assets | 120.87 | 115.89 | 22.16 | 42.52 | 21.16 | 20.85 |
Total Current Assets | 453.1 | 463.84 | 249.2 | 305.7 | 399.79 | 523.13 |
Property, Plant & Equipment | 417.62 | 418.88 | 319.86 | 380.64 | 361.44 | 368.49 |
Long-Term Investments | 3 | 3 | - | - | - | - |
Goodwill | 101.82 | 98.89 | 107.17 | 128.81 | 140.42 | 138.38 |
Other Intangible Assets | 145.04 | 146.11 | 166 | 169.43 | 189.61 | 203.62 |
Long-Term Accounts Receivable | 3.68 | 4.52 | 7.82 | 11.07 | - | - |
Long-Term Deferred Tax Assets | 47.15 | 45.8 | 45.62 | 34.69 | 15.78 | 1.59 |
Other Long-Term Assets | 19.42 | 6.3 | 14.54 | 12.93 | 8.52 | 13.9 |
Total Assets | 1,191 | 1,187 | 910.2 | 1,043 | 1,116 | 1,249 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 32.69 | 49.17 | 56.53 | 22.35 | 29.66 | 95.15 |
Accrued Expenses | - | - | - | - | 16.87 | 16.33 |
Short-Term Debt | 205.02 | 176.11 | 134.34 | 147.37 | 148.42 | 147.7 |
Current Portion of Long-Term Debt | 6.53 | 8.25 | 30.03 | 42.08 | 9.92 | - |
Current Portion of Leases | 32.44 | 40.38 | 32.73 | 32.32 | 21.27 | 24.37 |
Current Income Taxes Payable | - | - | - | - | 2.82 | 4.69 |
Current Unearned Revenue | 59.9 | 29.99 | 16.69 | 10.8 | 12.7 | 12.83 |
Other Current Liabilities | 33.9 | 38.4 | 37.63 | 28.18 | 31.01 | 27.13 |
Total Current Liabilities | 370.48 | 342.29 | 307.95 | 283.11 | 272.66 | 328.19 |
Long-Term Debt | 5.67 | 6.17 | 6.25 | 21.38 | 12.18 | - |
Long-Term Leases | 255.69 | 256.43 | 133.47 | 178.37 | 157.97 | 176.27 |
Other Long-Term Liabilities | 2.01 | 2.12 | 2.56 | 2.49 | - | 2.18 |
Total Liabilities | 633.84 | 607.01 | 450.24 | 485.34 | 442.81 | 506.63 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 973.99 | 973.99 | 723.99 | 572.39 | 572.39 | 511.71 |
Additional Paid-In Capital | 274.93 | 274.93 | 204.33 | 187.28 | 187.28 | 251.72 |
Retained Earnings | -676.63 | -637.91 | -444.93 | -272.14 | -167.98 | -243.23 |
Comprehensive Income & Other | -18.74 | -33.62 | -23.41 | -42.91 | -32.26 | -37.92 |
Total Common Equity | 553.55 | 577.39 | 459.97 | 444.62 | 559.44 | 482.27 |
Minority Interest | 3.44 | 2.94 | - | - | - | 260.2 |
Shareholders' Equity | 556.98 | 580.32 | 459.97 | 557.92 | 672.74 | 742.47 |
Total Liabilities & Equity | 1,191 | 1,187 | 910.2 | 1,043 | 1,116 | 1,249 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 505.34 | 487.33 | 336.82 | 421.52 | 349.75 | 348.33 |
Net Cash (Debt) | -317.3 | -278.4 | -295.24 | -349.11 | -207.86 | -186.15 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -3.26 | -2.99 | -4.30 | -6.10 | -3.69 | -3.67 |
Filing Date Shares Outstanding | 97.4 | 97.4 | 72.4 | 57.24 | 57.24 | 51.17 |
Total Common Shares Outstanding | 97.4 | 97.4 | 72.4 | 57.24 | 57.24 | 51.17 |
Working Capital | 82.63 | 121.55 | -58.75 | 22.59 | 127.13 | 194.94 |
Book Value Per Share | 5.68 | 5.93 | 6.35 | 7.77 | 9.77 | 9.42 |
Tangible Book Value | 306.69 | 332.38 | 186.8 | 146.38 | 229.41 | 140.28 |
Tangible Book Value Per Share | 3.15 | 3.41 | 2.58 | 2.56 | 4.01 | 2.74 |
Machinery | 127.98 | 122.35 | 119.75 | 116.21 | 75.91 | 127.91 |
Construction In Progress | - | - | - | - | 129.26 | 42.28 |
Leasehold Improvements | 150.2 | 145.37 | 138.89 | 135.01 | 24.91 | 54.63 |